CRW vs. ONT, UPR, PRTC, SPI, AMS, GNS, BMK, NIOX, MXCT, and OXB
Should you be buying Craneware stock or one of its competitors? The main competitors of Craneware include Oxford Nanopore Technologies (ONT), Uniphar (UPR), PureTech Health (PRTC), Spire Healthcare Group (SPI), Advanced Medical Solutions Group (AMS), Genus (GNS), Benchmark (BMK), NIOX Group (NIOX), MaxCyte (MXCT), and Oxford Biomedica (OXB). These companies are all part of the "medical" sector.
Oxford Nanopore Technologies (LON:ONT) and Craneware (LON:CRW) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, media sentiment, institutional ownership, community ranking, dividends, risk and profitability.
Craneware received 208 more outperform votes than Oxford Nanopore Technologies when rated by MarketBeat users. However, 100.00% of users gave Oxford Nanopore Technologies an outperform vote while only 71.43% of users gave Craneware an outperform vote.
Oxford Nanopore Technologies presently has a consensus target price of GBX 303.75, indicating a potential upside of 175.89%. Craneware has a consensus target price of GBX 2,600, indicating a potential upside of 13.04%. Given Craneware's higher probable upside, equities research analysts plainly believe Oxford Nanopore Technologies is more favorable than Craneware.
38.5% of Oxford Nanopore Technologies shares are held by institutional investors. Comparatively, 58.1% of Craneware shares are held by institutional investors. 30.0% of Oxford Nanopore Technologies shares are held by company insiders. Comparatively, 20.8% of Craneware shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Craneware has higher revenue and earnings than Oxford Nanopore Technologies. Oxford Nanopore Technologies is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks.
Craneware has a net margin of 5.19% compared to Craneware's net margin of -91.06%. Oxford Nanopore Technologies' return on equity of 2.86% beat Craneware's return on equity.
In the previous week, Oxford Nanopore Technologies had 1 more articles in the media than Craneware. MarketBeat recorded 5 mentions for Oxford Nanopore Technologies and 4 mentions for Craneware. Craneware's average media sentiment score of 1.27 beat Oxford Nanopore Technologies' score of 0.30 indicating that Oxford Nanopore Technologies is being referred to more favorably in the media.
Oxford Nanopore Technologies has a beta of 0.59, meaning that its share price is 41% less volatile than the S&P 500. Comparatively, Craneware has a beta of 0.13, meaning that its share price is 87% less volatile than the S&P 500.
Summary
Craneware beats Oxford Nanopore Technologies on 9 of the 17 factors compared between the two stocks.
Get Craneware News Delivered to You Automatically
Sign up to receive the latest news and ratings for CRW and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CRW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Craneware Competitors List
Related Companies and Tools
